DE69602983D1 - Darstellung von D4T aus 5-Methyluridin - Google Patents

Darstellung von D4T aus 5-Methyluridin

Info

Publication number
DE69602983D1
DE69602983D1 DE69602983T DE69602983T DE69602983D1 DE 69602983 D1 DE69602983 D1 DE 69602983D1 DE 69602983 T DE69602983 T DE 69602983T DE 69602983 T DE69602983 T DE 69602983T DE 69602983 D1 DE69602983 D1 DE 69602983D1
Authority
DE
Germany
Prior art keywords
methyluridine
preparation
making
another aspect
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69602983T
Other languages
English (en)
Other versions
DE69602983T2 (de
Inventor
Richard H Spector
Bang-Chi Chen
Sandra L Quinlan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69602983D1 publication Critical patent/DE69602983D1/de
Publication of DE69602983T2 publication Critical patent/DE69602983T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE69602983T 1995-03-10 1996-03-08 Darstellung von D4T aus 5-Methyluridin Expired - Fee Related DE69602983T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/402,283 US5608049A (en) 1995-03-10 1995-03-10 Preparation of d4T from 5-methyluridine

Publications (2)

Publication Number Publication Date
DE69602983D1 true DE69602983D1 (de) 1999-07-29
DE69602983T2 DE69602983T2 (de) 2000-03-09

Family

ID=23591286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69602983T Expired - Fee Related DE69602983T2 (de) 1995-03-10 1996-03-08 Darstellung von D4T aus 5-Methyluridin

Country Status (18)

Country Link
US (1) US5608049A (de)
EP (1) EP0735044B1 (de)
JP (1) JP3914279B2 (de)
KR (1) KR100393913B1 (de)
CN (2) CN1195770C (de)
AT (1) ATE181556T1 (de)
AU (1) AU694320B2 (de)
CA (1) CA2170968A1 (de)
CY (1) CY2155B1 (de)
DE (1) DE69602983T2 (de)
DK (1) DK0735044T3 (de)
ES (1) ES2135168T3 (de)
GR (1) GR3031243T3 (de)
HK (1) HK1002979A1 (de)
HU (1) HU220700B1 (de)
IL (1) IL117225A (de)
SG (1) SG38948A1 (de)
TW (1) TW527359B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
WO2002020538A2 (en) * 2000-09-06 2002-03-14 Bristol-Myers Squibb Company Stavudine polymorphic form 1 process
JP2007522094A (ja) * 2003-09-22 2007-08-09 アシドフィル エルエルシー 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4904770A (en) * 1988-03-24 1990-02-27 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
JP3128080B2 (ja) * 1991-10-02 2001-01-29 日本製紙株式会社 核酸化合物の新規な製造方法
US5539099A (en) * 1993-11-15 1996-07-23 Bristol-Myers Squibb Company Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine

Also Published As

Publication number Publication date
US5608049A (en) 1997-03-04
CN1147519A (zh) 1997-04-16
CN1059213C (zh) 2000-12-06
JPH08269051A (ja) 1996-10-15
IL117225A (en) 2001-04-30
HK1002979A1 (en) 1998-09-30
SG38948A1 (en) 1997-04-17
ES2135168T3 (es) 1999-10-16
GR3031243T3 (en) 1999-12-31
DK0735044T3 (da) 2000-01-10
EP0735044A1 (de) 1996-10-02
CA2170968A1 (en) 1996-09-11
KR960034212A (ko) 1996-10-22
AU694320B2 (en) 1998-07-16
CY2155B1 (en) 2002-08-23
JP3914279B2 (ja) 2007-05-16
IL117225A0 (en) 1996-06-18
CN1195770C (zh) 2005-04-06
CN1270172A (zh) 2000-10-18
DE69602983T2 (de) 2000-03-09
AU4798296A (en) 1996-09-19
KR100393913B1 (ko) 2003-12-18
TW527359B (en) 2003-04-11
ATE181556T1 (de) 1999-07-15
HUP9600607A1 (en) 1996-12-30
HU220700B1 (hu) 2002-04-29
EP0735044B1 (de) 1999-06-23

Similar Documents

Publication Publication Date Title
DZ1961A1 (fr) Nouveaux composés.
DE3876050D1 (de) Okulare hypotensivagenzien.
DE69602638D1 (de) Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
DE69722286D1 (de) Die Herstellung von Zwavel-enthaltende Organosiliziumverbindungen
DE69615453D1 (de) Verfahren zur Herstellung von mikrokapselhaltigen Zusammensetzungen
DZ1989A1 (fr) Nouveaux composés.
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE69614819D1 (de) Herstellungsverfahren von gefrorenen zusammensetzungen
DE59100581D1 (de) Verfahren zur herstellung von torfersatz, anlage zur durchführung dieses verfahrens, anwendung des verfahrens und nach diesem verfahren hergestellter torfersatz.
FR2715069B1 (fr) Procédé pour améliorer la rémanence d'une odeur.
DE69908533D1 (de) Verfahren zur Herstellung von 3,3,5-Trimethylcyclohexylidenebisphenolen
BR9611339A (pt) Processo de preparação de 1,3-propanediol
DE69918605D1 (de) Verfahren zur Herstellung von Kaliumoxonat
ATE181556T1 (de) Darstellung von d4t aus 5-methyluridin
EA199900741A1 (ru) Способ получения эпросартана
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
DE69614936D1 (de) d4T polymorphe Form I Verfahren
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DE69917445D1 (de) Reinigung von carboxaldehyd
DE69702961D1 (de) Herstellung von 1,1-difluorethan
DE69724216D1 (de) Pyridin-Zwischenprodukte, verwendbar zur Herstellung von Beta-adrenergischen Rezeptor-Agonisten
DE69908926D1 (de) Herstellung von hydrogensilanen durch katalytische hydrogenolyse von polysilanen
DE69811871D1 (de) Verfahren zur herstellung von uridine diphosphat-n-acetylglucosamine (13.04.99)
DE69503379D1 (de) Herstellung von tintenzusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee